Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Merck & Co. Inc.
IndexDJIA S&P500 P/E30.16 EPS (ttm)1.90 Insider Own0.04% Shs Outstand2.88B Perf Week1.20%
Market Cap165.32B Forward P/E16.10 EPS next Y3.56 Insider Trans3.41% Shs Float2.87B Perf Month-2.38%
Income5.61B PEG5.51 EPS next Q0.88 Inst Own75.30% Short Float0.80% Perf Quarter1.63%
Sales43.55B P/S3.80 EPS this Y-26.50% Inst Trans-0.29% Short Ratio2.30 Perf Half Y-0.10%
Book/sh16.58 P/B3.46 EPS next Y2.54% ROA5.40% Target Price63.30 Perf Year30.76%
Cash/sh4.64 P/C12.34 EPS next 5Y5.48% ROE11.50% 52W Range43.23 - 60.98 Perf YTD17.13%
Dividend1.76 P/FCF31.72 EPS past 5Y-16.50% ROI6.60% 52W High-5.03% Beta0.42
Dividend %3.07% Quick Ratio1.50 Sales past 5Y13.00% Gross Margin60.20% 52W Low33.96% ATR1.33
Employees77300 Current Ratio1.90 Sales Q/Q-0.70% Oper. Margin18.60% RSI (14)53.71 Volatility2.72% 2.26%
OptionableYes Debt/Eq0.48 EPS Q/Q126.70% Profit Margin12.90% Rel Volume1.01 Prev Close57.31
ShortableYes LT Debt/Eq0.38 EarningsOct 27 BMO Payout90.60% Avg Volume10.05M Price57.91
Recom2.50 SMA202.01% SMA50-1.10% SMA2002.50% Volume6,274,122 Change1.05%
30-Apr-14Reiterated Argus Buy $62 → $66
11-Apr-14Reiterated MKM Partners Buy $64 → $70
05-Feb-14Reiterated Argus Buy $54 → $62
14-Jan-14Reiterated MKM Partners Buy $59 → $64
03-Jun-13Reiterated MKM Partners Buy $54 → $59
15-Apr-13Reiterated Barclays Overweight $45 → $60
04-Feb-13Reiterated MKM Partners Buy $51 → $52
04-Feb-13Reiterated Barclays Overweight $46 → $45
20-Nov-12Upgrade MKM Partners Neutral → Buy $47 → $51
17-Oct-12Reiterated MP Advisors Outperform $45 → $50
30-Jul-12Reiterated UBS Buy $45 → $50
13-Jul-12Upgrade MP Advisors Market Perform → Outperform $45
03-Feb-12Reiterated Barclays Capital Overweight $38 → $40
03-Feb-12Downgrade MKM Partners Buy → Neutral $42 → $40
29-Nov-11Initiated MKM Partners Buy $38
14-Sep-11Reiterated Barclays Capital Overweight $41 → $38
16-May-11Reiterated UBS Buy $40 → $42
04-Feb-11Reiterated UBS Buy $42 → $40
24-Jan-11Reiterated Deutsche Bank Buy $48 → $43
24-Jan-11Reiterated Barclays Capital Overweight $43 → $41
30-Oct-14 04:01PM  The 4 DJIA Stocks That Dominated the Market at 24/7 Wall St.
11:31AM  Video: Bristol-Myers Lung-Cancer Drug Boosts Survival at Investor's Business Daily
09:35AM  Big Pharma Solid Q3 Earnings Put These ETFs in Focus Zacks
28-Oct-14 03:32PM  Stocks rally on earnings; Dow jumps 175 points at CNBC
03:26PM  Merck (MRK) Stock Continues to Fall After Third-Quarter Earnings Report at TheStreet
02:42PM  French Drugmaker Sanofi Warns Of Tougher Competition at Investor's Business Daily
02:00PM  Video: Facebook, Gilead Post Earnings After The Close at Investor's Business Daily
12:11PM  [$$] German Drug Firms Target China at The Wall Street Journal
09:38AM  Stock Market News for October 28, 2014 Zacks
05:55AM  [$$] Novartis Boosted by Stake Sale at The Wall Street Journal
27-Oct-14 04:26PM  Merck good medicine? Talking Numbers
04:22PM  Energy stocks sap S&P 500 at MarketWatch
03:38PM  Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble at Investor's Business Daily
03:34PM  Merck Conference Call Highlights Benzinga
03:26PM  Weak Merck sales overshadow third-quarter cost cuts Reuters
03:24PM  Weak Merck sales overshadow Q3 cost cuts Reuters
03:12PM  If It's Bad For Merck, It's Good For Gilead at Barrons.com
02:35PM  Merck shares slide after earnings decline at USA TODAY
12:47PM  [video] White House Pushes Back on Ebola Quarantines, and More at MarketWatch
12:29PM  3 Stocks, 3 trades: MRK, GRMN & SRPT CNBC
12:19PM  Merck (MRK) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
12:00PM  Merck Revenue Sags 4% in Third Quarter at New York Times
11:10AM  Merck 3Q adjusted profit tops analysts' estimates AP
11:03AM  Merck (MRK) Stock Lower After Announcing Third Quarter Earnings Results at TheStreet
10:12AM  [video]Merck's Q3 Results Beat Street on Bottom Line But Miss on Top at TheStreet
10:00AM  Merck Tops on Q3 Earnings, Patent Expiries Hit Revenues Zacks
09:59AM  Trade-Ideas: Merck (MRK) Is Today's Unusual Social Activity Stock at TheStreet
09:50AM  Expirations, drop in hep C drugs hit Merck sales at CNBC
09:45AM  Merck Shares Slip On Missed Revenue Despite 'Breakthrough' Designation For Cancer Treatment at Forbes
09:14AM  Twitter, DuPont, Bank of America and Merck are part of Zacks Earnings Preview: Zacks
09:02AM  Valeant may up bid for Allergan...again; Merck mixed results; Apple Pay mobile payment battle Hot Stock Minute
09:00AM  Mercks cost cutting pays off as results beat expectations at Fortune
08:40AM  Merck Earnings Look Very Mixed in Major Restructuring at 24/7 Wall St.
08:15AM  Checkup on big pharma CNBC
08:01AM  Early Movers: MRK, AGN, BABA, TSLA, F & more at CNBC
08:00AM  Merck & Co Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:46AM  [$$] Generics Again Hurt Merck Sales at The Wall Street Journal
07:28AM  Monsters under the bed threaten markets seasonal boost at MarketWatch
07:20AM  Wall Street struggles to keep up momentum; Merck's profit tops estimates; Apple Pay gets a setback Hot Stock Minute
07:18AM  Merck beats Q3 forecast, cost cuts offset Gardasil decline Reuters
07:07AM  Q3 2014 Merck & Co Inc Earnings Release - Before Market Open CCBN
07:06AM  MERCK & CO. INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:00AM  Merck Announces Third-Quarter 2014 Financial Results Business Wire
06:45AM  Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA┬« (pembrolizumab) in Advanced Non-Small Cell Lung Cancer Business Wire
06:17AM  Merck, Twitter earnings in focus on Wall Street at CNBC
26-Oct-14 05:02AM  Energy, health care earnings to dominate week at MarketWatch
25-Oct-14 08:30AM  Get ready for a week full of earnings reports at USA TODAY
24-Oct-14 06:00PM  Cramer's game plan for next week CNBC
04:10PM  Will Merck (MRK) Pull a Surprise this Earnings Season? Zacks
02:41PM  Ex-BNY Mellon Employee Pleads Guilty in Insider Case at Bloomberg
02:19PM  Your first trade for Monday at CNBC
01:40PM  Ex-Bank of New York Mellon trader pleads guilty to insider trading Reuters
01:23PM  Bristol-Myers Beats Q3 Views As Eliquis Revives at Investor's Business Daily
12:58PM  FMHR Final Trade: FTNT, MRK, AMZN & F CNBC
11:11AM  Whats on Tap Weekly Calendar Yahoo Finance Blogs
23-Oct-14 09:51AM  Could High Drug Prices Be Bad For Innovation? at Forbes
22-Oct-14 07:00PM  17 trades in 91 seconds CNBC
05:59PM  Fast Money Final Trade: HD, HYG, MRK, AMGN CNBC
04:44PM  Gilead's Hep C Dream Drug Faces Demanding Investors at Investor's Business Daily
20-Oct-14 01:00PM  Dow Jones (DJIA) Today: Merck (MRK) Higher at TheStreet
08:00AM  US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteurs Investigational Pediatric Hexavalent Vaccine Business Wire
08:00AM  Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals PR Newswire
18-Oct-14 09:57AM  Ebola Outbreak Shows The Dark Side Of Mother Nature at Forbes
17-Oct-14 06:37PM  U.S. cattle industry grapples with quality versus quantity Reuters
02:41AM  Roche, Merck extend immunotherapy fight to breast cancer Reuters
16-Oct-14 11:49AM  Merck and Ranbaxy Settle Allegations of Overcharging Medicaid Programs at The Wall Street Journal
11:10AM  Will Actavis Win Competition For Allergan's Affection? Benzinga
15-Oct-14 05:09PM  MERCK & CO. INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:04PM  Merck unit to pay $31 mln to settle fraud claims by U.S. states Reuters
01:20PM  Cramer: The Bears on the Move -- and the Panic Is Palpable at TheStreet
08:00AM  Merck Announces Final Results of Tender Offers for Eight Series of Notes Business Wire
12:01AM  Repo Rules, Tipper Charged, Broken Windows: Compliance at Bloomberg
14-Oct-14 07:25PM  Ex-financial analyst facing insider trading charge AP
06:20PM  Merck Announces Pricing of Tender Offers for Eight Series of Notes Business Wire
04:52PM  Ex-Merck analyst faces insider trading charges on merger tips Reuters
12:00PM  Ex-Merck Analyst Charged With Telling Friend of Buyout at Bloomberg
10:48AM  Former Merck analyst faces insider trading charges on merger tips Reuters
13-Oct-14 04:33PM  IPO Calendar: Biotech Companies Lead List Of 7 IPOs at Investor's Business Daily
01:59PM  Alnylam Drug Scores Against Rare Nerve Disease at Investor's Business Daily
01:00PM  Dow Jones (DJIA) Today: Merck (MRK) Lower at TheStreet
08:07AM  5 Companies That Could Develop An Enterovirus Treatment Benzinga
10-Oct-14 05:17PM  New once-a-day pill for hepatitis C wins FDA OK AP
09-Oct-14 06:25PM  Cramer: Activists are picking on the wrong chiefs at CNBC
05:44PM  What's the Dollar Value of Online Patient Chatter? at BusinessWeek
02:00PM  Scientists find lung cancer can lie hidden for 20 years Reuters
09:00AM  Why companies like BAE and Bayer issued debt in US markets Market Realist
02:18AM  Glaxo Agrees to Take 25% Stake in Aspen Pharmacare Japanese Unit at Bloomberg
08-Oct-14 06:38PM  Merck to release hep C data Investor's Business Daily
05:20PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
04:01PM  The 4 Stocks That Dominated the Market 24/7 Wall St.
02:00PM  Stocks extend gains on FOMC minutes; Dow up 100 points at CNBC
01:36PM  Merck, Bristol, Arrowhead Prep Hepatitis Studies at Investor's Business Daily
11:13AM  Merck to Present New Data from Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-5172/MK-8742) at the 65th American Association for the Study of Liver Diseases Annual Meeting Business Wire
10:00AM  Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, E I Du Pont De Nemours & Company (DD) Lags at TheStreet
07-Oct-14 04:51PM  Ebola vaccine use likely to be confined, experts say at MarketWatch
11:13AM  Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo at Investor's Business Daily
06-Oct-14 01:36PM  New Issue- Merck & Co prices multi tranche deal Reuters
12:38PM  Merck & Co., Inc. -- Moody's rates Merck's new euro notes A2; stable outlook at Moody's
12:28PM  Merck Prices EUR 2.5 Billion Debt Offering Business Wire
11:41AM  Merck sale boosts Europe's corporate bond market at Financial Times
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEOOct 10Option Exercise34.2012,875440,272351,440Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOOct 10Sale59.739,895591,033341,545Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOSep 10Option Exercise34.2012,875440,272348,379Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOSep 10Sale60.489,814593,592338,565Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM